Methotrexate Sodium
- Product NDC
- 64850-330
- 11-digit product format
- 648500330
- Labeler code
- 64850
- Product ID
- 64850-330_030a6bcf-d482-4c98-9d27-423235cdb930
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methotrexate Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Elite Laboratories, Inc.
- Application
- ANDA216453
- Marketing category
- ANDA
- Marketing start
- 2024-05-16
- Substance
- METHOTREXATE SODIUM
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Methotrexate Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METHOTREXATE SODIUM | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3IG1E710ZN |
| Rxcui | 105585 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64850-330-01 | Methotrexate Sodium | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64850-330 | METHOTREXATE SODIUM TABLET [ELITE LABORATORIES, INC.] | 2 | Current NDC, 1 package rows | 20240524_89c05ea3-3be1-46dd-b112-29c436fd7289.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 64850-330-01 | 64850033001 | 100 TABLET in 1 BOTTLE, PLASTIC (64850-330-01) | 100 tablet | 2024-05-16 | No | No | Historical |